Visual Analysis of Cell Death in Bladder Cancer -- A Bibliometrics-Based Comprehensive Study
Zhiwen Cao, Yueyi CheniD, Nan-xi Fu, Furui Fu, Sen-jie Shi, Hongyu WangiD, Chuanglong Xu
Abstract
Cell death mechanisms offer therapeutic strategies for bladder cancer, yet lack comprehensive bibliometric analysis. Map global research trends and hotspots in bladder cancer cell death mechanisms via bibliometrics. We analyzed 5,392 publications (1991-2024) from Web of Science using VOSviewer (co- authorship/keyword clustering), CiteSpace (citation bursts), and GraphPad Prism (statistics). Metrics included: (1) Temporal trends, (2) Country/institution contributions, (3) Journal impact, (4) Citation dynamics, (5) Collaboration networks, (6) Conceptual hotspots. China and the US led research output. Top institutions:University of Texas System (USA; 178 publications), UTMD Anderson Cancer Center (USA; 123), Nanjing Medical University (China; 122), Journal of Urology had the highest output (106 publications); Cancer Research (IF:12.5) the highest impact. Kim Wun-Jae was the most productive author (37 articles); Jemal A the most co-cited (446 citations). Keyword and citation analyses revealed emerging integration of cell death mechanisms with immunotherapy (IT) and photodynamic therapy (PDT) to overcome chemoresistance. This study delineates the evolution of bladder cancer cell death research and identifies IT/PDT as promising resistance-overcoming strategies grounded in targeted cell death pathways.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TRPV4 Channels Mediate Bladder Cancer Cell Proliferation, Migration and Chemoresistance
Venkatesh Katari, Kesha K. Dalal, … Charles Kumar Thodeti·Journal of Pharmacology and Experimental TherapeuticsPeer-reviewed·Jul 22, 2025
- CD44v6 Drives Tumor Aggressiveness and Chemoresistance in Bladder Cancer
Iris Lodewijk, Carolina Rubio, … Marta Dueñas·bioRxiv·Aug 27, 2025
- Anti-cancer properties of cannabidiol and Δ9-tetrahydrocannabinol and potential synergistic effects with gemcitabine, cisplatin and other cannabinoids in bladder cancer
A. M. Tomko, E. G. Whynot, D. J. Dupre·bioRxiv·Mar 25, 2021
- SMAD3-driven cell state transitions underpin immunoresistance in bladder cancer
Sarah Y. T. Robertson, Jing Yang, … Boris Ν. Kholodenko·bioRxiv·Oct 22, 2026
- Analysis and Identification of Necroptosis Landscape on Therapy and Prognosis in Bladder Cancer
- Tumor microenvironment exploration and therapeutic target identification in bladder cancer based on Cuproptosis signature and chemotherapy-resistant model: results from bioinformatics and experimental validation
Jun Gu, Zhenduo Shi, … Conghui Han·bioRxiv·May 23, 2023